muscle loss on semaglutide impacts skeletal to a similar extent as caloric restriction in mice with diet‐induced obesity - Jeromson - The Journal of Physiology See how semaglutide paired with

"The analyses from STEP UP presented at ECO are really promising, further highlighting the potential of the higher dose of Wegovy to achieve substantial weight loss," said Emil Kongshj Larsen, Novo Nordisk's head of international operations

Unlike standard clinics that simply write a prescription, our semaglutide weight loss program is integrated with our core regenerative and anti-aging therapies to deliver a comprehensive transformation

Your healthcare provider will help you determine the appropriate duration of treatment

The active substance in Wegovy, semaglutide, is a GLP-1 receptor agonist that acts in the same way as GLP-1, a natural hormone in the body

I emphasize practical strategies that support metabolic health, preserve lean mass, and promote sustainable outcomes

The findings were presented at ENDO 2026, the Endocrine Society's annual meeting